Back

Echocardiographic screening for cardiac amyloidosis using artificial intelligence: A multi-site study for algorithm training and external validation.

1 September 2024 (09:00 - 09:11)
Organised by: Logo
Congress Presentation Part of: Basic and Translational Late-Breaking Science Technology ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Patricia Ann Pellikka

Mayo Clinic, Rochester (United States of America)

7 More presentations in this session

Presentation thumbnail
Gut Microbiota and Associated Metabolites Play a Key Role in the Pathogenesis of the Obesity Phenotype of Heart Failure With Preserved Ejection Fraction
Associate Professor R. Asleh (Jerusalem, IL)
Slides Video
Presentation thumbnail
Distinct cellular and molecular trajectories leading to subclinical diastolic dysfunction and the progression to HFpEF
Doctor E. Lara-Pezzi (Madrid, ES)
Slides Video
Presentation thumbnail
Different cardiovascular outcomes of vascular ageing proteomic phenogroups in normotensive and hypertensive individuals: results from the UK Biobank.
Professor T. Guzik (Edinburgh, GB)
Slides Video
Presentation thumbnail
Polygenic traits and cardiac remodelling contribute to a markedly increased risk of atrial fibrillation in former elite endurance athletes
Professor A. La Gerche (Melbourne, AU)
Slides Video
Presentation thumbnail
An isocaloric high fat diet enriched with saturated compared to polyunsaturated fat has a more detrimental effect on clinical cardiometabolic risk factors in healthy humans
Mr N. Srnic (Oxford, GB)
Slides Video

Access the full session

Session thumbnail
Basic and Translational Late-Breaking Science
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Identification of at-risk populations for cardiac amyloidosis: a multimodal machine learning development and validation study
thumbnail
Congress Presentation
Detection and risk stratification of cardiac amyloidosis patients by integration of imaging and non-imaging data using a machine learning approach
thumbnail
Congress Presentation
CA-AI Echo – Diagnosis of cardiac amyloidosis on echocardiography using artificial intelligence: a multicentre international development and validation study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources